BCS Private Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Sell
1,452
-60
-4% -$15.8K 0.12% 125
2026
Q1
$403K Buy
1,512
+25
+2% +$6.77K 0.12% 124
2025
Q4
$373K Sell
1,487
-20
-1% -$5.31K 0.13% 120
2025
Q3
$433K Buy
1,507
+105
+7% +$28.1K 0.15% 104
2025
Q2
$368K Buy
+1,402
New +$341K 0.14% 112

Other funds holding LH

BCS Private Wealth Management's LH Position: Q2 2026 in Review

BCS Private Wealth Management reduced its Labcorp (LH) stake by 4% in Q2 2026, selling an estimated $15.8K and leaving 1,452 shares worth $407K. The position accounts for 0.12% of the portfolio, ranked #125.

BCS Private Wealth Management first reported a position in LH in Q2 2025 and has held it in 5 quarters since. The position peaked at $433K in Q3 2025. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • BCS Private Wealth Management held 1,452 shares of Labcorp worth $407K as of Q2 2026.
  • BCS Private Wealth Management sold 60 Labcorp shares in Q2 2026, an estimated $15.8K.
  • Labcorp made up 0.12% of BCS Private Wealth Management's portfolio in Q2 2026, its #125 holding.
  • BCS Private Wealth Management first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
  • BCS Private Wealth Management's Labcorp position peaked at $433K in Q3 2025.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.